Medco Energi Internasional Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Medco Energi Internasional Tbk. trades at Rp1,555 (market cap 39.46T, 55.01M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Medco Energi Internasional Tbk. is far larger — about 378× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MEDC | SCPI | |
|---|---|---|
Market Cap | 39.46T | 104.4B |
Volume | 55.01M | — |
Lot | 550.06K | — |
Turnover | 87.49B | — |
Average Price | 1,590.64 | — |
Value | 87.49B | — |
Indicative Equilibrium Price | 1,555 | — |
Indicative Equilibrium Volume | 13.38K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Medco Energi Internasional Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970, based on notarial deed No. 19 of Imas Fatimah, S.H., dated June 9, 1980. Medco Energi Corporation is holding company for energy related business within the Medco Group of companies. On March 1997 the company cooperated with Myanmar Oil and Gas Enterprise plan to handle 8,000 m2 of suspended field in Myanmar. Company is a PMDN
Read more on MEDC →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →